Can Bacteria Treat Cancer, and Other Links

Can bacteria treat cancer? It is cheap, easy to produce and noninvasive.

71%  of Republican voters want health care law repealed. Only 16 percent of Democratic voters do.

Secret rebates encourage doctors to prescribe a drug costing 100 times more than an identical drug. $2,000 versus $20.

UK’s NICE loses its rationing powers. About 20,000 patients die unnecessarily early each year because of NICE decisions.

Comments (6)

Trackback URL | Comments RSS Feed

  1. Joe S. says:

    Glad to see NICE is being reined in. 20,000 deaths? That’s an abomination.

  2. Bruce says:

    On Republicans and Deomocrats, elections matter. What else is there to say?

  3. Tom H> says:

    Secret rebates? Isn’t that illegal?

  4. Ken says:

    NICE is coming to a health plan near you. And it won’t be very nice.

  5. Linda Gorman says:

    The rebate was to encourage the use of an expensive “on-label” drug treatment rather than a cheap “off-label” drug treatment. The on-label drug is way more expensive as sombody has to pay for that FDA approval.

    The article says that there will be a government sponsored RCT trial of the two drugs shortly.

    In the meantime, I’m confused. Don’t government programs like Medicaid take a dim view of off-label drug use? Wasn’t the Avastin contraversy solely about off-label use in breast cancer?

    According to a New York Times editorial last year the fact that medicare adopted rules to expand coverage for “off-label” uses of cancer drugs was A Bad Thing. It said that “the danger in expanding usage without strong evidence of safety and effecitveness is that patients may be harmed.”

    Who knew that a side effect of the politicization of health care would be the massive headache induced by having to keep up with what one is supposed to think.

  6. Devon Herrick says:

    NICE used a $34,000 cost per life year saved to determine whether to cover costly cancer drugs. This framework is being replaced by “value-based pricing” where bureaucrats consider the effectiveness and compare the cost of alternative drugs and dictate the price they are willing to pay. It’s hardly a change from the way it’s done by NICE.